Replies to post #151 on Rigel Pharmaceuticals Inc (RIGL)

[Planopenny]

rigl it...just a little bit :) weeeeeeee

[mlkrborn]

RIGL -29.6% (AstraZeneca reports top-line results from OSKIRA-1 Phase 3 study of Fostamatinib in Rheumatoid Arthritis, Rigel Pharma downgraded to Market Perform from Outperform at BMO Capital Mkts),